NCT06245876Completed
Lung EpiCheck Biomarkers Development Study
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2132 (actual)
- First submitted
- 30 Jan 2024
- Start date
- 17 May 2022
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Nucleix Ltd.
- Diseases
- Lung cancer
- NCT number
- NCT06245876
What you commit to
- Study type: Observational
- Participants enrolled: 2132
- From 17 May 2022 to the primary completion date, 31 Jan 2026
- 10 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not previously diagnosed with a lung lesion highly suspicious for cancer
- Acute exacerbation or flare of an inflammatory condition requiring escalation in medical therapy within 14 days prior to blood draw
- Any history of blood product transfusion within 30 days prior to blood draw
Other illness
- Known diagnosis or treatment of cancer from any kind in the past 5 years, except of fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix and except from the current lung cancer
- \- Known diagnosis or treatment of cancer of any kind in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix
- Known diagnosis or treatment of cancer of any kind in the past (lifetime), except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix.
- Under follow up or work up for any lesion suspicious for any type of cancer
Other
- Presenting with fever with body temperature 100.4°F (38°C) or higher
- Pregnancy
Who the study is looking for
- Age 50-80 years
- Subjects who are currently smoking or former smokers, with at least 20 pack-years
- Subjects with either A high suspicion for lung cancer, with planned biopsy or surgery to establish a definitive diagnosis within 60 days after enrollment or treatment naive lung cancer patients confirmed by pathology.
- Age 50-80 years
- Subjects who are currently smoking or former smokers, with at least 20 pack-years
- Age 20-80 years
- Never smoker or current / previous smoker \< 20 pack year history
Age in the registry: 20 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Koranyi Institute For Pulmonology Coordinator of this site? Confirm its status | Budapest | Hungary | Unknown status |
| Carmel Medical Center Coordinator of this site? Confirm its status | Haifa | Israel | Unknown status |
| Sourasky Medical Center Coordinator of this site? Confirm its status | Tel Aviv | Israel | Unknown status |
| ZGT Medical Center Coordinator of this site? Confirm its status | Hengelo | Netherlands | Unknown status |
| Life Spring Clinical Research Coordinator of this site? Confirm its status | Miami | United States | Unknown status |
| Emerald Coast OBGYN Coordinator of this site? Confirm its status | Panama City | United States | Unknown status |
| Urology San Antonio Coordinator of this site? Confirm its status | San Antonio | United States | Unknown status |
| Ochsner LSU Health Shreveport - Regional Urology Coordinator of this site? Confirm its status | Shreveport | United States | Unknown status |
| Comprehensive Urology Coordinator of this site? Confirm its status | Southfield | United States | Unknown status |
| Michigan Institute of Urology, P.C. Coordinator of this site? Confirm its status | Troy | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.